Journal article
Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia
Abstract
BACKGROUND: Adult Helicobacter pylori-positive patients by 13C-urea breath test with uninvestigated dyspepsia symptoms were randomized to 1-week eradication treatment with omeprazole, metronidazole and clarithromycin (OMC) vs. omeprazole and placebo antimicrobials (OPP) in the Canadian Adult Dyspepsia Empiric Treatment-H. pylori-positive (CADET-Hp) study.
AIM: To perform an economic evaluation of this 1-year study.
Authors
Chiba N; Van Zanten SJOV; Escobedo S; Grace E; Lee J; Sinclair P; Barkun A; Armstrong D; Thomson ABR
Journal
Alimentary Pharmacology & Therapeutics, Vol. 19, No. 3, pp. 349–358
Publisher
Wiley
Publication Date
February 2004
DOI
10.1111/j.1365-2036.2004.01865.x
ISSN
0269-2813